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Abstract
Several lines of evidence indicate altered trafficking of a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)
receptors in schizophrenia. Previous reports have shown potential changes in the trafficking of AMPA receptors based on
subunit expression of endosomes, subcellular organelles located near post-synaptic sites. We hypothesized that alterations
in AMPA receptor trafficking through the endoplasmic reticulum (ER) may also be altered in schizophrenia. Accordingly, we
developed a technique to isolate and measure content of the ER from postmortem brain tissue. We used Western blot and
electron microscopy to show that we isolated an ER enriched fraction. We found no changes in the expression of the AMPA
receptor subunits, GluR1–4, in the ER from the dorsolateral prefrontal cortex in schizophrenia. These data suggest that
AMPA receptor trafficking through the ER is largely intact in schizophrenia.
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Introduction
Schizophrenia, a severe mental illness, may be linked to
abnormalities of glutamate receptor neurotransmission and
expression [1–3]. Recent findings support the hypothesis that
alterations in glutamate neurotransmission may be part of the
underlying pathophysiology of schizophrenia [4]. Recent evidence
also implicates abnormalities in trafficking of AMPA-type gluta-
mate receptors in this illness [5–7]. Alterations of AMPA receptor
interacting proteins, as well as altered subcellular localization of
AMPA receptor subunits, have also been described [5,6].
The AMPA receptor consists of four subunits, GluR1–4, that
are typically assembled as dimers into a tetrameric complex in the
endoplasmic reticulum (ER) [8,9]. AMPA receptor subunit
composition influences the rate of transit of AMPA receptors
through the ER, with AMPA receptors containing GluR1/GluR2
subunits trafficking faster than GluR2/GluR3 containing recep-
tors [10]. Additionally, AMPA receptor interacting proteins alter
the rate of trafficking of AMPA receptors through the ER and to
the synapse. Synapse-associated protein 97 (SAP97) binds to the
PDZ (postsynaptic density 95/Discs large/zona occludens-1)
domain of GluR1 in GluR1/GluR2 hetero-oligomers for fast
trafficking from the ER to the Golgi [11,12]. Protein interacting
with C Kinase 1 (PICK1) binds to the C-terminal domain of
GluR2 in GluR2/GluR3 containing receptors, leading to slower
exit from the ER [10]. Trafficking of assembled AMPA receptors
from the ER to the distal dendrites occurs along the cytoskeletal
spine. Glutamate Receptor Interacting Protein 1 (GRIP1) interacts
with GluR2 containing receptors and kinesin motor proteins to
bring assembled AMPA receptors along the dendrites to the
synapse [13–15]. AMPA receptors in the distal dendrites can be
surface expressed at the synapse in an activity-dependent manner
[16,17]. Surface expressed AMPA receptors can be removed from
and returned to the synapse in a tightly regulated endosomal
system, facilitating changes in synaptic strength [18].
Previous studies have measured the expression of AMPA
receptor protein and mRNA at a regional level and found no
changes in schizophrenia [19–21]. Recent studies have examined
expression of AMPA interacting proteins and subcellular localiza-
tion of AMPA receptors in schizophrenia [5,7,22]. In postmortem
human dorsolateral prefrontal cortex samples, we have previously
found an increase in the AMPA receptor GluR1 subunit in early
endosomes and no difference in the expression of AMPA receptor
subunits in late endosomes [5,22]. Additionally, SAP97 and
GRIP1 were increased in schizophrenia, suggesting an increase in
the rate of forward trafficking of AMPA receptors from the ER to
the synapse [5].
Based on these findings, we hypothesized that accelerated
proximal forward trafficking and decreased ER retention of
AMPA receptor subunits may be associated with the pathophys-
iology of schizophrenia. To further test this hypothesis, we
developed a technique to isolate ER from postmortem human
brain tissue, characterized this ER fraction, and measured the
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39190expression of AMPA receptor subunits in this fraction from
subjects with schizophrenia and a comparison group.
Results
Endoplasmic Reticulum Isolation and Characterization
We used differential sucrose gradient centrifugation to obtain an
ER enriched fraction from postmortem brain tissue (Figure 1). In
addition to an enriched ER fraction, we obtained 3 other fractions.
To verify and characterize the identity of each fraction, we used a
wide screen of antibodies specific for various subcellular compart-
ments (Figure 2). As expected, bands for each antibody were
present in total brain homogenate. In the nuclear fraction (pellet
1), we detected calnexin (an ER marker), histone3 (a nuclear
marker), Grp75 (a mitochondrial marker), PSD95 (a post-synaptic
density marker), a 1,2-mannosidase (a Golgi marker), and GluR2.
In the mitochondrial fraction (pellet 2), we detected calnexin,
Grp75, PSD95, a 1,2-mannosidase, and GluR2. In the light
membrane/cytosol fraction (supernatant 3), we detected Grp75,
and EEA1 (an early endosome marker). The putative ER fraction
(pellet 4) contained high levels of calnexin as well as GluR2, which
is expected to be in the ER [23–25].
Enriched subcellular fractions were further characterized using
electron microscopy (Figure 3). The nuclear fraction (pellet 1)
contained an enrichment of nuclei as well as postsynaptic density-
like structures. The mitochondrial fraction (pellet 2) contained an
enrichment of mitochondria and postsynaptic density-like struc-
tures. The light membrane/cytosol fraction (supernatant 3) was
void of mitochondria, nuclei, or postsynaptic density-like struc-
tures. As expected, pellet 4 largely contained structures resembling
ER microsomes and did not contain mitochondria, nuclei, or
postsynaptic density-like structures.
AMPA Subunit Protein Expression in Total Homogenate
We measured the expression by Western blot analysis of the
AMPA receptor subunits, GluR 1–4, in total homogenate samples.
Protein expression in the total homogenate was measured relative
to the amount of protein loaded. We found no significant changes
in GluR1, GluR2, GluR3, or GluR4 in the total homogenate in
the schizophrenia group compared to the comparison group. We
found no significant correlations between protein expression and
age, pH, or PMI. In addition, we found no influence of sex on the
expression of these subunits.
AMPA Subunit Protein Expression in Enriched
Endoplasmic Reticulum
We examined the expression of the AMPA receptor subunits,
GluR 1–4, in the ER fraction (Figure 4). Protein expression in
the enriched ER samples was measured relative to the
corresponding protein in the total homogenate lane. We found
no significant changes in GluR1, GluR2, GluR3, or GluR4 in
the enriched ER fraction in the schizophrenia group compared
to the comparison group. We found no significant correlations
between protein expression and age, pH, or PMI in our enriched
ER samples. In addition, we found no influence of sex on these
protein levels.
In order to assess the validity of our normalization strategy, we
also normalized expression of GluR3 and GluR4 to the intra-lane
expression of the ER chaperone protein Jena Muenchen antibody
4 (JM4). The expression of JM4 was not changed in either the total
homogenate or the ER fraction. We found no significant changes
in GluR3 or GluR4 expression normalized to JM4 in the enriched
ER fraction (data not shown). Due to technical limitation we were
unable to perform these analyses for GluR1 and GluR2. We found
no significant correlations between protein expression (normalized
to JM4) and age, pH, or PMI and no influence of sex on protein
levels in our enriched ER samples.
Discussion
We have previously reported increased expression in DLPFC
in schizophrenia of SAP97 and GRIP1, two proteins involved in
the forward trafficking of AMPA receptors from the ER to the
synapse [5]. We also found an increase in GluR1 protein
expression in one distal compartment, in a cohort where we did
not find changes in total GluR1 expression [5]. Taken together,
these previous findings suggest alterations in the subcellular
localization of AMPA receptors in schizophrenia. To extend this
Figure 1. Flow chart of endoplasmic reticulum isolation.
Nitrogen cavitation of tissue was followed by a series of centrifugation
steps and sucrose density gradient centrifugation.
doi:10.1371/journal.pone.0039190.g001
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subunits, GluR1–4, in an ER enriched fraction from human
brain.
Based on Western blot protein characterization and electron
microscopy, we have identified contents of the four fractions
obtained using our differential sucrose gradient centrifugation
Figure 2. Neurochemical characterization of subcellular fractions isolated from postmortem human frontal cortex. Fractions enriched
for endoplasmic reticulum (P4), cytosol and ‘light’ membranes (S3), mitochondria (P2), and nuclei (P1) were assayed by Western blot for
compartment-specific markers: Calnexin (ER), histone3 (Nuc), glucose regulated 75 kDa protein (Grp75, Mito), early endosome antigen 1 (EEA1,
endosomes), postsynaptic density 95 (PSD95, PSD), and a1,2 mannosidase (a1,2-Man, Golgi). The PSD segregated with the other ‘heavy’ membranes
in the Mit and Nuc fractions. As expected, AMPA receptor subunit 2 (GluR2) was detected in the ER and fractions containing the PSD.
doi:10.1371/journal.pone.0039190.g002
Figure 3. Assessment of enriched subcellular fractions isolated from postmortem human frontal cortex by electron microscopy.
100 mg of total unfractionated sample (T, 1650x magnification), endoplasmic reticulum (P4, 11,000x), light membranes and cytosol (S3, 4,400x),
mitochondria (P2, 11,000x), and nuclei (P1, 1650x) were processed for electron microscopy. The ER and L/C fractions do not have intact Mit, Nuc, or
postsynaptic density (PSD)-like structures. The Mit and Nuc fractions have PSD-like structures (black arrows).
doi:10.1371/journal.pone.0039190.g003
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the ER (calnexin and GluR2) but no markers from other
compartments (histone3, GRP75, EEA1, PSD95, and a 1,2-
mannosidase). The Western blot and electron microscopy profile
of supernatant 3 implies that this fraction contains light
membranes and cytosol. The presence in this fraction of Grp75,
a stress protein typically found in the mitochondrial matrix, may
indicate a loss of integrity of mitochondria either during the
postmortem interval or processing of the samples. We found that
pellet 2 contained post-synaptic densities and intact mitochondria
while pellet 1 contained post-synaptic densities and intact nuclei.
There is evidence of contamination in these fractions with calnexin
and a 1,2-mannosidase, suggesting some breakdown of ER and
mitochondrial membranes. Importantly, our fraction of interest,
the ER fraction, is generally free from contamination by other
subcellular organelles, including mitochondria, nuclei, and post-
synaptic densities.
Compared to a previous report of ER isolation using
immunoprecipitation with magnetic beads, the ER isolation
protocol used in this study yields an ER fraction the has been
verified to be free from contaminants by Western blot and electron
microscopy [4]. While both studies provide the ability to measure
the relative amount of glutamate receptor subunits within an ER
fraction, the technique used in this study suggests that the sample is
not contaminated by Golgi or other membranes [4].
Previously, we found an increase in GluR1 in early endosomes
[5]. We also examined the expression of AMPA receptor subunits
in late endosomes and found no change in expression [22]. Other
studies using the same subject cohort found evidence of alterations
in the proteins involved in the trafficking, expression, and signaling
of the AMPA receptor subunits [7]. Thus, we expanded the
examination of the subcellular localization of the AMPA receptors
in schizophrenia. We found no change in the total GluR1–4
AMPA receptor subunit expression in schizophrenia, suggesting
that the total expression of AMPA receptor subunits is unchanged
between the groups. Using the expression of AMPA receptor
subunits in total homogenate as a control, we measured the AMPA
receptor subunits in the ER fraction relative to the amount in the
Figure 4. Western blot analysis of AMPA Receptor subunit expression in enriched endoplasmic reticulum fraction (A – GluR1, B –
GluR2, C – GluR3, D – GluR4) normalized to relative expression in total homogenate. Representative blots of ER fraction. Error bars
represent standard deviation. GluR1: F(1,30)=0.57558, p=0.45. GluR2: F(1,30)=0.00725, p=0.93. GluR3: F(1,30)=0.28370, p=0.59. GluR4:
F(1,32)=0.15205, p=0.69.
doi:10.1371/journal.pone.0039190.g004
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in the ER in schizophrenia, suggesting that although AMPA
receptor interacting proteins responsible for the trafficking of
AMPA receptors from the ER to the synapse are increased in
schizophrenia, the expression of the AMPA receptor subunits
themselves is not altered in the ER in this illness.
To assess the validity of our normalization strategy, we also
analyzed the expression of GluR3 and GluR4 relative to the same-
lane expression of the ER chaperone protein JM4 [26]. JM4 is a
good candidate for normalization as it is ubiquitously expressed in
ER and was unchanged in schizophrenia (data not shown) in both
the ER fractions and the total homogenate samples. Similar to the
results normalized to total GluR subunit expression, we found no
significant change in the expression of GluR3 or GluR4
normalized to JM4. Since both normalization strategies yielded
the same results for GluR3 and GluR4, we propose that our
primary normalization strategy may be a valid approach for
fractionation studies utilizing postmortem tissues.
Similar to other studies using postmortem tissue, there are
technical limitations associated with this work. It is conceivable
that small changes below our level of detection may be present in
schizophrenia and our negative findings are the result of a Type
II error. Further, while there was no correlation with expression
of any of the subunits with age, all of the subjects included in this
study were from an older population, and these findings may not
be generalizable to younger patients. The effect of antipsychotic
treatment was not assessed in this study because of the small
number of available patients off antipsychotic medications at the
time of death. It has been shown previously that prolonged
treatment of rodents with antipsychotics can alter the expression
of some AMPA receptor subunit mRNA and protein expression
[27–29]. Thus, we cannot exclude that this lack of an effect
might be due to normalization of these subunits by antipsychotic
treatment.
In summary, we found no significant changes in the expression
of AMPA receptor subunits in the ER in DLPFC in schizophre-
nia. In our previous studies, we examined distal AMPA receptor
trafficking in schizophrenia, while in the current study we
examined proximal localization of AMPA receptors. With the
exception of our earlier GluR1 finding in early endosomes, our
findings suggest that proximal and distal subcellular localization
of AMPA receptors is largely unchanged in schizophrenia.
However, AMPA receptor interacting proteins responsible for the
trafficking of the receptors, SAP97 and GRIP1, are increased in
schizophrenia. [5]. It may be that the function of these proteins
relative to AMPA receptor trafficking is intact, but other
modalities of trafficking involving these proteins are disturbed
in this illness. Alternatively, the increase in SAP97 and GRIP1
may be counteracted by a previously reported decrease in
PICK1, another AMPA receptor interacting protein involved in
trafficking of the receptors [7]. In the present manuscript, we did
not measure expression of AMPA interacting proteins localized
to the ER, but it must be considered that changes in interacting
protein expression may be altered in an enriched ER fraction.
Further refinement of the isolation technique and secondary
protein expression analysis may also allow for the measurement
of post-translational modifications of AMPA receptors as well as
determining interactions between AMPA receptors in the ER
and as they are trafficked in the neurons.
Recent literature has suggested that the AMPA receptor
subunits may be variably trafficked within the dendrites [30]. It
has been suggested that the trafficking of AMPA receptors
containing GluR1 subunits may follow the canonical trafficking
modality while the receptors containing GluR2 subunits may be
trafficked via dendrite-localized ER [31]. We hypothesized that
trafficking of AMPA receptor subunits was altered in schizophre-
nia. The complex trafficking system suggesting alternative routes
for individual AMPA receptor subunits further exemplifies the
need to look at the contents of each subcellular compartment that
is involved in AMPA receptor trafficking. Importantly, the
subcellular expression of the AMPA receptors in isolated recycling
endosomes and the postsynaptic density has not been examined in
schizophrenia, areas that we are actively pursuing.
Table 1. Paired Subject Demographics.
Pair Subject Sex/Age, y pH PMI, h
1 Comparison F/63 6.20 20.2
Schizophrenia F/62 6.74 23.7
2 Comparison F/73 6.98 3
Schizophrenia F/71 6.60 5.5
3 Comparison F/74 6.32 4.7
Schizophrenia F/75 6.49 21.5
4 Comparison F/76 6.46 4.2
Schizophrenia F/77 6.01 9.7
5 Comparison F/79 6.38 10.1
Schizophrenia F/79 6.80 9.9
6 Comparison F/81 6.37 19.4
Schizophrenia F/81 6.67 15.1
7 Comparison F/85 6.30 4.3
Schizophrenia F/84 6.64 NA
8 Comparison F/96 6.30 4.5
Schizophrenia F/89 6.20 9.6
9 Comparison M/59 6.67 20.4
Schizophrenia M/57 6.40 20.6
10 Comparison M/65 6.82 3.8
Schizophrenia M/66 6.50 12.1
11 Comparison M/69 6.67 7.4
Schizophrenia M/70 6.35 7.1
12 Comparison M/73 6.17 14.9
Schizophrenia M/73 7.30 11.7
13 Comparison M/76 6.32 2.9
Schizophrenia M/76 6.70 16.5
14 Comparison M/84 6.83 11.4
Schizophrenia M/84 6.71 17.7
15 Comparison M/93 6.28 4.1
Schizophrenia M/92 6.67 17.7
16 Comparison M/68 6.55 2.7
Schizophrenia M/70 6.36 17.3
17 Comparison M/75 6.43 5.0
Schizophrenia M/78 6.64 26.1
18 Comparison M/95 6.53 4.1
Schizophrenia M/97 6.50 9.2
Abbreviations: Years (y), Postmortem Interval (PMI). Hours (h). Female (F). Male
(M). Not available (NA).
doi:10.1371/journal.pone.0039190.t001
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Subjects
Subjects from the Mount Sinai Medical Center brain bank were
recruited prospectively and underwent extensive antemortem
diagnostic and clinical assessment (Table 1). Exclusion criteria
included a history of alcoholism, substance abuse, death by
suicide, or coma for .6 h before death. Consent was obtained
from next of kin for each subject. Brains were collected and cut
coronally into 10 mm slabs. The left dorsolateral prefrontal cortex
was dissected from the coronal slabs, snap frozen, and stored at
280uC. This tissue was pulverized, adding small amounts of liquid
nitrogen as necessary, and stored at 280uC until used. Each of the
eighteen (18) subjects with schizophrenia was matched for sex, and
as closely as possible, for age and tissue pH with one comparison
subject. Subjects groups did not significantly differ in mean age or
tissue pH (Table 2). Subject groups did significantly differ in length
of postmortem interval; however PMI was not correlated with
expression of any of these subunits.
ER Isolation
Isolation of an ER enriched fraction was performed in parallel
for each pair of subjects, one control and one schizophrenia
subject, using nitrogen cavitation and differential sucrose gradient
centrifugation (modified from [32]) (Figure 1). A starting amount
of about 65 mg of pulverized tissue was used for each subject. All
steps were carried out on ice or at 4uC for the centrifugation steps.
Pulverized tissue was reconstituted in 1.2 mL of 1X ER extraction
buffer (Sigma Aldrich) and subjected to nitrogen cavitation at 450
psi for 8 minutes. A 60 mL aliquot of this was saved as total
homogenate. A low speed centrifugation (7006g) for 10 minutes
was used to remove intact nuclei and large cellular debris (pellet 1).
A subsequent 150006g centrifugation for 10 minutes of the
supernatant (supernatant 1) was done to pellet intact mitochondria
(pellet 2). The resulting supernatant (supernatant 2) was loaded
onto a three-layered sucrose gradient (2.0 M sucrose, 1.5 M
sucrose, and 1.3 M sucrose) and centrifuged at 1260006g for
70 minutes on a Beckman L8-M ultracentrifuge in a SW60Ti
rotor (Beckman). Following this centrifugation, the upper 200 mL
of supernatant was collected (supernatant 3) and 100 to 300 mLo f
a dense white band between the top layer and the 1.3 M sucrose
layer was collected (pellet 3). Pellet 3 was gently mixed by inversion
with ice cold MTE buffer (premixed with 200 mM PMSF buffer).
This mixture was centrifuged at 1260006g for 45 minutes
resulting in a large, translucent pellet (pellet 4).
For each subject, pellets 1 and 2 were each reconstituted in
500 mL of PBS and pellet 4 was reconstituted in 50 mL of PBS. All
samples were stored at 220uC until ready for use.
Electron Microscopy
To visualize the content and confirm morphology of each
fraction, samples were prepared for electron microscopy as
previously described [5]. Briefly, fractions were fixed with 4%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight at
room temperature. Samples were then washed and treated with
1% osmium tetroxide for 1 h, mordanted with 0.25% uranyl
acetate in acetate buffer for 30 min to overnight, washed and
dehydrated with a graded series of ethanol washes and propylene
oxide. Finally, the samples were embedded in epoxy resin, thin
sectioned and counterstained with uranyl acetate and lead citrate.
Images were captured using an FEI Tecnai Spirit 20–120kv
Transmission Electron Microscope.
Western Blot Analysis
Prior to Western blot analysis, the amount of protein in each
fraction was measured using a BCA protein assay kit (Thermo
scientific). For each pair of subjects, samples for Western blot were
prepared in duplicate with 5–10 mg of protein for each fraction
placed in reducing buffer containing b-mercaptoethanol and
heated at 70uC for 10 minutes. Protein loaded was consistent for
each fraction within subject pairs, but not necessarily between
subject pairs. Samples were then run by SDS-PAGE on Invitrogen
(Carlsbad, California) 4–12% gradient gels, and transferred to
PVDF membrane using Bio-Rad semi-dry transblotter (Hercules,
California). Membranes were blocked in LiCor (Lincoln, Ne-
braska) blocking buffer for 1 h at room temperature before
overnight incubation at 4uC with commercially available antibod-
ies in 0.1% Tween LiCor blocking buffer with antisera dilutions
determined empirically (Table 3). Following incubation, mem-
branes were washed four times for 5 minutes each with PBS.
Membranes were probed with IR-dye labeled secondary antibody
in 0.1% Tween, 0.01% SDS LiCor blocking buffer for 1 h at room
temperature in the dark. Membranes were washed again with PBS
four times for 5 minutes each and then briefly rinsed three times in
distilled water. The blots were stored in distilled water at 4uC until
scanned using the LiCor Odyssey laser-based image detection
method [33,34].
Data Analysis
Image analysis from ER isolation Western blot studies was
performed as previously described [5,34]. Briefly, near-infrared
fluorescent signals obtained from the LiCor Odyssey scanner were
expressed as raw integrated intensity with top-bottom median
intralane background subtraction using Odyssey 3.0 analytical
software (LiCor). Protein band intensity for each protein in the ER
isolation was normalized to the protein band intensity for the same
protein in the total homogenate lane. All statistical analyses were
performed using Statistica 7.1 (Statsoft, Tulsa, Oklahoma).
Correlation analyses were carried out to identify any associations
between the dependent variables and pH, age, and postmortem
interval. One-way analysis of covariance (ANCOVA) was
performed to analyze differences in GluR1–4 expression if
significant correlations were found. If no correlations were present,
data were analyzed with one-way analysis of variance (ANOVA).
An additional secondary analysis was performed using sex as the
independent measure.
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Table 3. Antibodies used for western blots
Antibody Species Concentration Company
Calnexin Rabbit 1:5000 CalBiochem, Gibbstown, NJ
Histone3 Rabbit 1:1000 Cell Signaling, Danvers, MA
Grp75 Rabbit 1:5000 Abcam Inc., Cambridge, MA
EEA1 Mouse 1:500 BD Bioscience, San Jose, CA
PSD95 Mouse 1:1000 Millipore, Bellarica, MA
a 1,2-Mannosidase Rabbit 1:1000 Abcam Inc., Cambridge, MA
GluR1 Rabbit 1:200 US Biological, Swampscott, MA
GluR2 Mouse 1:1000 US Biological, Swampscott, MA
GluR3 Rabbit 1:200 US Biological, Swampscott, MA
GluR4 Goat 1:100 Santa Cruz Biotechnology, Santa Cruz, CA
Abbreviations: Glucose Regulated 75 kDa Protein (GRP75). Early Endosome Antigen 1 (EEA1). Postsynaptic Density 95 (PSD95). Ionotropic Glutamate Receptor 1 (GluR1).
Ionotropic Glutamate Receptor 2 (GluR2). Ionotropic Glutamate Receptor 3 (GluR3). Ionotropic Glutamate Receptor 4 (GluR4).
doi:10.1371/journal.pone.0039190.t003
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